Is Vitamin C Immune Support Randomized Trial safe?

Updated July 2026

Quick Answer

Vitamin C Immune Support Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points.

Key Takeaways

  • 01Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points. [Iversen PO (2026)]
  • 02Conclusion Whether routine vitamin A supplementation is warranted for GVHD prevention, needs further study. [Iversen PO (2026)]
  • 03Introduction Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. [Iversen PO (2026)]
  • 04Methods We conducted a 1:1 randomized controlled trial with extracorporeal photopheresis for GVHD-prophylaxis as the intervention. [Iversen PO (2026)]
The current Migaku evidence database contains 2 reusable source documents for Vitamin C Immune Support Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points. [Iversen PO (2026); evidence level 2] - Conclusion Whether routine vitamin A supplementation is warranted for GVHD prevention, needs further study. [Iversen PO (2026); evidence level 2] - Introduction Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. [Iversen PO (2026); evidence level 2] - Methods We conducted a 1:1 randomized controlled trial with extracorporeal photopheresis for GVHD-prophylaxis as the intervention. [Iversen PO (2026); evidence level 2] - Resistance often develops through genetic changes in fungi, such as mutations in drug targets or increased drug efflux. [Akimbekov Nuraly S. (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial.
  2. Vitamin D–AMP axis in host defense against fungal infections